Psoriatic Arthritis (PsA) is underdiagnosed in dermatology clinics in individuals with psoriasis and can create delays in treatment. Our client, a top 10 pharma company, wanted dermatologists to own the conversation on PsA, and become confident in diagnosing the disease. Deep insight mining through qualitative research, patient journey analysis, and interviews were needed to understand the unmet need and provide key actionable insights to develop a strategy for an educational program.
This transformative program drove awareness of the importance of earlier diagnosis and increased skills and knowledge for dermatologists on how to confidently perform a joint exam to assess their patients with psoriasis for signs of PsA. In addition to the content co-created with our leading medical experts, the program was endorsed in partnership with associated centers of excellence.
At Inizio, we partner with you to provide a full range of congress capabilities – powering connection and simplifying the complex. Get in touch to learn more about our full-service congress solutions here.
Our client was new to the complement system space and was preparing to launch an oral, first-in-class medication in a rare blood disease.
Read moreA top 10 global pharma company wanted to challenge the status quo when it came to planning and prioritizing congresses.
Read morePROPENSITY4 was able to deliver a final targeting scheme in 8 weeks for a small Life Sciences organization.
Read more